Abstract: Purpose To investigate whether tumor volume derived from apparent diffusion coefficient (ADC) maps (VolumeADC) and tumor mean ADC value (ADCmean) are independent predictors of prostate tumor Gleason score (GS). Materials and Methods Tumor volume and GS were recorded from whole-mount histopathology for 131 men (median age, 60) who underwent endorectal diffusion-weighted magnetic resonance imaging for local staging of prostate cancer before prostatectomy. VolumeADC and ADCmean were derived from ADC maps and correlated with histopathologic tumor volume and GS. Uni-and multivariate analyses were performed to evaluate prediction of tumor aggressiveness. Areas under receiver-operating-characteristics curves (AUCs) were calculated to evaluate the performance of VolumeADC and ADCmean in discriminating tumors of GS 6 and GS 7. Results Histopathology identified 116 tumor foci >0.5 mL. VolumeADC correlated significantly with histopathologic tumor volume (=0.683). The correlation increased with increasing GS (=0.453 for GS 6 tumors; =0.643 for GS 7 tumors; =0.980 for GS8 tumors). Both VolumeADC (=0.286) and ADCmean (=-0.309) correlated with GS. At univariate analysis, both VolumeADC (p=0.0325) and ADCmean (p=0.0033) could differentiate GS=6 from GS7 tumor foci. However, at multivariate analysis, only ADCmean (p=0.0156) was a significant predictor of tumor aggressiveness (i.e., GS 6 vs. GS 7). For differentiating GS 6 from GS7 tumors, AUCs were 0.644 and 0.704 for VolumeADC and ADCmean, respectively, and 0.749 for both parameters combined. Conclusion In patients with prostate cancer, ADCmean is an independent predictor of tumor aggressiveness, but VolumeADC is not. The latter parameter adds little to the ADCmean in predicting tumor Gleason score. 
Abstract Purpose
To investigate whether tumor volume derived from apparent diffusion coefficient (ADC) maps (Volume ADC ) and tumor mean ADC value (ADC mean ) are independent predictors of prostate tumor Gleason score (GS).
Materials and Methods
Tumor volume and GS were recorded from whole-mount histopathology for 131 men (median age, 60) who underwent endorectal diffusion-weighted magnetic resonance imaging for local staging of prostate cancer before prostatectomy. Volume ADC and ADC mean were derived from ADC maps and correlated with histopathologic tumor volume and GS. Uni-and multivariate analyses were performed to evaluate prediction of tumor aggressiveness. Areas under receiver-operating-characteristics curves (AUCs) were calculated to evaluate the performance of Volume ADC and ADC mean in discriminating tumors of GS 6 and GS ≥7.
Introduction
It was estimated that 30% to 50% of the approximately 238,590 American men diagnosed with prostate cancer (PCa) in 2013 would have an indolent form of the disease unlikely to become life-threatening. These men could potentially take advantage of an increasing spectrum of patient-tailored disease management optionsincluding active surveillance and various forms of focal ablation-that are designed to minimize adverse treatment-related effects (1-3). However, to ensure that patients are indeed suited for such conservative management approaches, it is essential not only to detect and localize PCa, but also to assess its aggressive potential-a task that remains challenging. Clinical, biochemical and pathological features are typically used to triage patients according to the likelihood of rapid disease progression (4) (5) (6) (7) (8) .
Recently, diffusion-weighted magnetic resonance imaging (DWI) has garnered interest for its potential to non-invasively characterize PCa aggressiveness. DWI probes variations in free water movement within tissues, which tends to be more restricted in the presence of tumor due to changes in cell number, size and architecture. On DWI images, variations in water diffusion manifest as changes in signal intensity, and degrees of diffusion restriction can be assessed quantitatively by means of the apparent diffusion coefficient (ADC). A relatively simple metric, the ADC can be calculated on a pixel-by-pixel basis with clinical MRI platforms. A number of studies have shown an inverse correlation between ADC values on DWI and prostate cancer Gleason scores (9) (10) (11) (12) (13) (14) . However, the ADC values of PCa foci with different Gleason scores overlap, and no method has been developed to determine the Gleason score unequivocally based on ADC analysis alone (9) (10) (11) (12) (13) (14) .
Research. Pathology studies have shown that higher tumor volumes are associated with higher Gleason scores and worse outcomes (15, 16) . Tumor volume measured on DWI correlates well with the histopathologic tumor volume (17, 18) . However, the relationship between ADC and prostate tumor volume and the potential synergy of these two parameters in evaluating PCa aggressiveness have not been explicitly explored. Thus, the purpose of our study was to investigate whether tumor mean ADC value and tumor volume derived from ADC maps are independent predictors of tumor Gleason score and can be used to distinguish tumors with Gleason scores of 6 from those with Gleason scores of 7 or above.
Materials and Methods
The institutional review board approved our retrospective study and waived the informed consent requirement. Our study was compliant with the Health Insurance Portability and Accountability Act.
Patients
Patients who underwent MRI of the prostate including DWI between July 2008
and April 2010 and for whom whole-mount step-section pathologic tumor maps were available were identified (n=377). Patients who met the following inclusion criteria were selected: 1) 1.5-Tesla MRI of the prostate, including a DWI sequence with b=0, 1000 s/mm 2 ; 2) radical prostatectomy performed at our institution within 6 months after MRI.
Patients were excluded if a) they had undergone prior prostate cancer treatment, including hormone therapy or radiation; b) acquisition was incomplete or imaging artifacts rendering the examination non-diagnostic were present; or c) MRI was performed without an endorectal coil. Our final study population consisted of 131
consecutive patients who were previously included in a study analyzing histogramderived apparent diffusion coefficient (ADC) parameters (19) . Patients' characteristics are summarized in Supplemental Table 1 .
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Histopathologic Preparation
After prostatectomy, specimens were submitted to histopathology, where they were sliced from apex to base at 3-4-mm intervals. Microslices were placed on glass slides and stained with hematoxylin-eosin after paraffin embedding. For each patient, one of two dedicated genitourinary pathologists at our institution with more than 30 years of combined experience verified,and assigned a Gleason score for (GS) for each tumor outlined on the histology slides.
Measurement of Histopathologic Tumor Volume
Tumor volume on pathology slices was measured in consensus by two of the authors using software (ImageJ, version 1.47a; National Institutes of Health, Bethesda, Md). If a lesion extended into more than one pathologic slice, the areas of tumor foci on all slices were summed to obtain an estimate of the histopathologic volume of the whole lesion. Tumors that covered both zones -the transition zone (TZ) as well as the peripheral zone (PZ) -were considered to be TZ tumors if more than 70% of the tumor was in the TZ (20) ; all others were considered to be PZ tumors (9) .
Correlation of Lesions on MRI and Histopathology
Working in consensus, three radiologists (with 1, 1 and 9 years of experience in interpreting prostate MRI,) correlated MR images with whole-mount pathology maps to establish the locations of tumors on MRI. Using software (ImageJ, version 1.47a; National Institutes of Health, Bethesda, Md), the radiologists drew a freehand region of interest around the discernible tumor tissue on the ADC maps (19) . If a tumor was depicted on more than one slice, all traced ROIs corresponding to that tumor were included in the estimation of the tumor volume (Volume ADC ) and the calculation of the mean ADC value (ADC mean ) (19) . On each slice containing tumor, the area of the tumor focus was determined on a voxel-basis by considering the acquisition matrix, reconstruction matrix as well as the FOV. Volume ADC [mL] was calculated as (sum of all tumor areas on the slices (cm 2 ) x slice thickness (cm)).
Statistical Analysis
The correlation between Volume ADC and volume derived from histopathology as well as the correlations of Volume ADC and ADC mean with tumor GS were assessed using Spearman's correlation coefficient (ρ). The between-subject correlation coefficient proposed by Bland and Altman (21) was calculated and tested to take into account multiple lesions per patient.
Research. To evaluate whether Volume ADC and ADC mean could differentiate a GS of 6 from a GS ≥ 7, a generalized linear regression and generalized estimating equations method was used with an independent correlation structure and robust covariance matrix, to take into account multiple lesions per patient. Univariate and multivariate analyses with both Volume ADC and ADC mean as covariates were performed. The odds ratio (OR) describing the likelihood of a tumor having GS≥7, along with the 95% confidence interval (CI), was estimated. Nonparametric receiver operating characteristic (ROC) curve analysis was performed, and the area under the curve (AUC) was estimated to evaluate the performance of Volume ADC and ADC mean in discriminating between GS 6 and GS≥7. Sensitivity and specificity based on the estimated probabilities from the multivariate model were used to estimate the AUC for the combination of both variables. 
Results
Forty-six patients presenting only insignificant cancer lesions in terms of volume (≤0.5mL) (22) were excluded from comparative analysis. One hundred sixteen clinically significant lesions (>0.5mL) on histopathology were found in 85 patients. Eighty-nine (76.7%) of the 116 lesions originated in the PZ and 27/116 (23.3%) originated in the TZ.
Lesion characteristics including tumor volume and GS are shown in Supplemental Table 2 .
Correlation of Volume ADC and Histopathologic Tumor Volume
The Spearman's correlation coefficient for Volume ADC and histopathologic tumor volume in lesions >0.5 mL was ρ=0.683 (p<0.0001) (Figure 1) . The correlation coefficient increased as the tumor GS increased, rising from ρ=0.453 (p=0.1042) for tumors with a GS of 6 (3+3), to ρ=0.643 (p<0.0001) for tumors with a GS of 7 (3+4 or 4+3) and ρ=0.980 (p<0.0001) for tumors with a GS ≥ 8 ( Table 1) . The correlation between histopathologic tumor volume and Volume ADC was highest for tumors of GS≥8. 
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Differentiation of Tumor Aggressiveness by Volume ADC and ADC mean
In a univariate analysis including all lesions (PZ and TZ), both Volume ADC and ADC mean could differentiate tumors of GS 6 from those with a GS ≥ 7 (odds ratio, 1.73
for Volume ADC and 0.64 for ADC mean ; p-values, p=0.0325 and p=0.0033, respectively) ( Table 2 ). In a sub-analysis considering only tumors originating in the PZ, ADC mean ,could differentiate between tumors of GS 6 and those with a GS ≥ 7 (p=0.0025), but Volume ADC could not (p=0.2709) ( Table 2 ). The number of lesions originating in the TZ was too small to permit a sub-analysis.
In a multivariate analysis, after adjustments were made for the influence of Volume ADC , ADC mean independently discriminated between tumors of GS 6 and tumors with a GS ≥ 7 (p=0.0156) (Figure 2) . However, after adjustments were made for the influence of ADC mean, Volume ADC could not independently differentiate between these two tumor Gleason score categories (p=0.0733) (Table 2, Figure 3 ).
Accuracy in discriminating tumors of GS 6 from those with a GS ≥ 7 was slightly lower for Volume ADC than for ADC mean (AUC=0.644 and AUC=0.704, respectively; (24) . Likewise the correlation between ADC mean and GS in our patient cohort (ρ=-0.31) was within the range of such correlations reported in recent studies (ρ=-0.26 to -0.38) (12, 14, 24) . At multivariate analysis, ADC mean was the only parameter that independently predicted the category of the tumor GS (GS 6 vs. GS ≥ 7). It appears that though the predictive value of ADC mean for tumor aggressiveness is independent of tumor size, when ADC mean is not clearly predictive, Volume ADC cannot be used to resolve the ambiguity. These results contrast with those of a recent study by Verma et al., in which both mean ADC value and Volume ADC were identified as significant predictors of tumor aggressiveness in the PZ at multivariate analysis (24) . There are several possible reasons for the discrepancy. We acknowledge the following limitations of our study: First, so that we would be able to correlate imaging findings with histopathology, we only included patients who underwent radical prostatectomy, causing a selection bias. Therefore our results may not apply to a broader population of patients with newly diagnosed prostate cancer, especially since there is a trend for increasing use of active surveillance of low-risk prostate cancer (27) . However, this selection bias is inherent to every study that uses whole-mount step-section histopathology specimens as a reference standard for evaluating imaging variables. Second, an endorectal coil was used for acquisition of MRI, potentially deforming the prostate gland and the tumor foci. However, the use of an endorectal coil provides a higher signal-to-noise ratio (28) and may therefore be preferable for quantitative ADC analysis. Third, our approach of retrospectively delineating the prostate cancer foci on ADC maps using the histopathology maps as a guide does not represent the sequence of events in the clinical setting, where histopathology maps would not be available at the time of MRI. Therefore, we are not able to provide information on the accuracy of prostate cancer detection in this study or on the effect that potentially missed lesions might have had on our results. 
potential bias in the evaluation of lesion volume on ADC maps as the location of tumors was available to the radiologists encircling the tumor foci. Although, the ROI drawn by the radiologists for the purposes of this study only contained clearly discernible tumor tissue on ADC maps (e.g. voxels that were visually darker than the surrounding healthy tissue), we acknowledge that the correlations reported in this study would be influenced by the diagnostic accuracy of prostate cancer detection in routine clinical practice.
In summary, our results suggest that while Volume ADC is useful to predict true tumor volume, ADC mean is the more useful parameter for distinguishing between GS 6 and higher-Gleason-score tumors -a distinction that is critical for identifying suitable candidates for active surveillance.
